A man from Quebec, aged 64, has made history in North America by being the first recipient of a regenerated liver, thanks to cutting-edge technology that could potentially increase the number of available livers for transplantation significantly in its initial year. Gérard Landry, a resident of Nouvelle in Quebec, faced liver issues for around 15 years, which eventually led to cirrhosis and liver cancer. Prior to his liver transplant surgery, his physician surprised him with news that the organ had been regenerated using a novel machine at Montreal’s Centre hospitalier de l’Université de Montréal (CHUM).
This innovative technology, known as Liver Assist, enables medical professionals to treat and evaluate a donated liver outside the body before transplanting it. For Landry, this meant receiving a liver that might have been deemed too risky for transplantation otherwise.
Dr. David Hénault, a liver transplant specialist at CHUM, who spearheaded the project and conducted Landry’s surgery, mentioned that the team had been preparing for the technology’s implementation for approximately three years. The Liver Assist system functions by connecting a donated liver to a machine that circulates an oxygen-rich solution through the organ, potentially reversing damage caused by oxygen deprivation during the organ’s extracorporeal state.
Hénault emphasized that the technology offers a platform to assess liver functionality under conditions mimicking the human body, indicating that if the liver performs well on the machine, it is likely to function appropriately in the recipient. The liver Landry received was especially suitable for this technology due to its vulnerability to oxygen-related damage during the transfer process.
CHUM typically conducts about 70 liver transplants annually, and a collaborative study with Transplant Québec explored the possibility of salvaging previously declined livers for transplantation using this groundbreaking technology. The team estimates that the machine could make an additional 20 to 24 livers available for transplantation in its first year, with potential for further growth as the technology gains wider acceptance.
Hénault expressed optimism about the technology’s ability to reduce complications, reoperations, and hospital stays for eligible patients. Landry exhibited promising signs of a successful transplant shortly after the operation, with his post-operative blood work already surpassing expectations.
As Landry continues his recovery in Montreal, with regular blood tests to adjust his medication, he eagerly anticipates returning to Gaspésie in the future for further recuperation. His positive experience has instilled in him a desire to reunite with his loved ones and horses, inspiring him to advocate for organ donation conversations, as advanced technology alone cannot address organ scarcity. Landry aptly summarized the importance of organ donation by stating, “if you have a horse without a rider, you don’t have a ride.”